TY  - JOUR 
AU  - Toribio García, Irene
AU  - Olivares Hernández, Alejandro
AU  - Miramontes González, José Pablo
AU  - Posado Domínguez, Luis
AU  - Martín García, Ana
AU  - Eiros Bachiller, Rocío
AU  - Figuero Pérez, Luis
AU  - Garijo Martínez, María
AU  - Roldán Ruiz, Jonnathan
AU  - Bellido Hernández, Lorena
AU  - Fonseca Sánchez, Emilio
AU  - Sánchez, Pedro Luis
AU  - Barco Morillo, Edel del
PY  - 2023
SN  - 2072-6694
UR  - https://uvadoc.uva.es/handle/10324/66668
AB  - Simple Summary: Immunotherapy is the mainstay treatment for most solid tumours. However, its cardiotoxicity is not yet known and studied, and its uncertainty is even greater in elderly patients. For this reason, this ambispective study was conducted...
AB  - Introduction: Immunotherapy represents a key pillar of cancer treatments, with high response rates and long survival. Its use is increasing, mainly at the expense of the geriatric population due to the ageing of this population. However, despite its...
LA  - eng
PB  - MDPI
KW  - Immunotherapy
KW  - Inmunoterapia
KW  - Cancer - Immunotherapy
KW  - Cáncer - Inmunoterapia
KW  - Oncology
KW  - immune checkpoint inhibitors
KW  - Cancer - Immunological aspects
KW  - Older people
KW  - Personas de edad
KW  - Cardiotoxicity
KW  - Cardiovascular system - Diseases
KW  - Cardiovascular, Aparato - Enfermedades
TI  - Cardiotoxicity secondary to immune checkpoint inhibitors in the elderly: Safety in real-world data
DO  - 10.3390/cancers15174293
ER  -